Histogen Performance

HSTODelisted Stock  USD 0.03  0.00  0.00%   
The company retains a Market Volatility (i.e., Beta) of 0.64, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Histogen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Histogen is expected to be smaller as well. Histogen right now retains a risk of 0.0%. Please check out Histogen jensen alpha and kurtosis , to decide if Histogen will be following its current trending patterns.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Histogen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Histogen is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
  

Histogen Relative Risk vs. Return Landscape

If you would invest  2.70  in Histogen on November 22, 2025 and sell it today you would earn a total of  0.00  from holding Histogen or generate 0.0% return on investment over 90 days. Histogen is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Histogen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Histogen Target Price Odds to finish over Current Price

The tendency of Histogen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.03 90 days 0.03 
about 73.43
Based on a normal probability distribution, the odds of Histogen to move above the current price in 90 days from now is about 73.43 (This Histogen probability density function shows the probability of Histogen Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Histogen has a beta of 0.64. This usually indicates as returns on the market go up, Histogen average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Histogen will be expected to be much smaller as well. Additionally Histogen has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Histogen Price Density   
       Price  

Predictive Modules for Histogen

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Histogen. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Histogen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.020.030.03
Details
Intrinsic
Valuation
LowRealHigh
0.020.030.03
Details
Naive
Forecast
LowNextHigh
0.070.070.07
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.030.04
Details

Histogen Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Histogen is not an exception. The market had few large corrections towards the Histogen's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Histogen, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Histogen within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-1.46
β
Beta against Dow Jones0.64
σ
Overall volatility
0.10
Ir
Information ratio -0.11

Histogen Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Histogen for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Histogen can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Histogen is not yet fully synchronised with the market data
Histogen has some characteristics of a very speculative penny stock
Histogen has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 19 K. Net Loss for the year was (12.38 M) with loss before overhead, payroll, taxes, and interest of (3.26 M).
Histogen currently holds about 12.6 M in cash with (10.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from J Finley: Disposition of 3896 shares by J Finley of Palisade Bio at 1.75 subject to Rule 16b-3

Histogen Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Histogen Stock often depends not only on the future outlook of the current and potential Histogen's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Histogen's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding3.2 M
Cash And Short Term Investments12.5 M

Histogen Fundamentals Growth

Histogen Stock prices reflect investors' perceptions of the future prospects and financial health of Histogen, and Histogen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Histogen Stock performance.

About Histogen Performance

By examining Histogen's fundamental ratios, stakeholders can obtain critical insights into Histogen's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Histogen is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California. Histogen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people.

Things to note about Histogen performance evaluation

Checking the ongoing alerts about Histogen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Histogen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Histogen is not yet fully synchronised with the market data
Histogen has some characteristics of a very speculative penny stock
Histogen has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 19 K. Net Loss for the year was (12.38 M) with loss before overhead, payroll, taxes, and interest of (3.26 M).
Histogen currently holds about 12.6 M in cash with (10.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from J Finley: Disposition of 3896 shares by J Finley of Palisade Bio at 1.75 subject to Rule 16b-3
Evaluating Histogen's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Histogen's stock performance include:
  • Analyzing Histogen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Histogen's stock is overvalued or undervalued compared to its peers.
  • Examining Histogen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Histogen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Histogen's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Histogen's stock. These opinions can provide insight into Histogen's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Histogen's stock performance is not an exact science, and many factors can impact Histogen's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Consideration for investing in Histogen Stock

If you are still planning to invest in Histogen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Histogen's history and understand the potential risks before investing.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Global Correlations
Find global opportunities by holding instruments from different markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators